Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine

Epilepsy Research

Volumn 41, Issue 3, 2000, Pages 253-257

  Verrotti, A ^a   Pascarella, R ^a   Trotta, D ^a   Giuva, T ^a   Morgese, G ^b   Chiarelli, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Carbamazepine; Epilepsy; Folate; Homocysteine; Pyridoxal 5' phosphate; Sodium valproate

Indexed keywords

CARBAMAZEPINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXAL 5 PHOSPHATE; VALPROIC ACID;

ADOLESCENT; AMINO ACID METABOLISM; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; EPILEPSY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; HOMOCYSTEINE; HUMANS; MALE; VALPROIC ACID;

EID: 0034308118     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00150-9     Document Type: Article

References (21)

1. Andersson A., Lindgren A., Hultberg B. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin. Chem. 41:1995;361-366.
2. Botez M., Young S. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 114:1991;333-348.
3. Cordoba-Porras A., Sanchez-Quesada J.L., Gonzales-Sastre J., Ordonez-Llanos J., Blanco-Vaca F. Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinaemia. J. Mol. Med. 74:1996;771-776.
4. Fröscher W., Maier V., Laage M. Folate deficiency, anticonvulsant drugs and psychiatric morbidity. Clin. Neuropharmacol. 18:1995;165-182.
5. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth cells. J. Biol. Chem. 262:1987;1098-1103.
6. Hishida R., Nau H. VPA-induced neural tube defects in mice: I: altered metabolism of sulfur amino acids and glutathione. Teratog. Carcinog. Mutagen. 18(2):1998;49-61.
7. Kishi T., Fujita N., Eguchi T., Ueda K. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy. J. Neurol. Sci. 145:1997;109-112.
8. May R., Sunder T. Hematologic manifestations of long-term valproate therapy. Epilepsia. 34:1993;1098-1101.
9. Ono H., Sakamoto A., Eguchi T. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism. 48:1997;959-962.
10. Schreiner P.J., Wu K.K., Malinow M.R., Nieto F.J., Heiss G. Plasma homocysteine and hemostasis: the ARIC Study. Circulation. 89:1994;S11.
11. Schwaninger M., Ringleb P., Winter R. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia. 40:1988;345-350.
12. Schwarz S., Zhou G.-Z. N-methyl-D-aspartate receptors and CNS symptoms of homocystinuria. Lancet. 337:1991;1226-1227.
13. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocyseinemia in an elderly population. J. Am. Med. Assoc. 270:1993;2693-2698.
14. Stampfer M.J., Malinow R., Willett W.C. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J. Am. Med. Assoc. 268:1992;877-881.
15. Tsai J.C., Perrella M.A., Yoshizumi M. et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA. 91:1994;6369-6373.
16. Ubbink J.B., Vermaak W.J.H., Van der Merwe A., Becker P.J. Vitamin B12, vitamin B6 and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin. Nutr. 57:1993;47-53.
17. Ubbink J.B., Van der Merwe A., Delport R. et al. The effect of a subnormal vitamin B6 status on homocysteine metabolism. J. Clin. Invest. 98:1996;177-184.
18. Ueland P.M., Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J. Lab. Clin. Med. 144:1989;473-501.
19. Van den Berg M., Boers G.H.J., Franken D.G. et al. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur. J. Clin. Invest. 25:1995;176-181.
20. Verrotti A., Basciani F., Domizio S. et al. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr. Neurol. 19:1998;364-367.
21. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. New Engl. J. Med. 338:1998;1042-1050.